Jonathan P. Kalehoff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jonathan P. Kalehoff has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Suzanne Oparil
Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, School of Medicine The University of Alabama at Birmingham (UAB), Birmingham, USA
1 shared publication- Suzanne Oparil
University of Alabama at Birmingham
1 shared publication
Latest Publications
- Open Access
- 3 February 2021
- Published by Springer Nature in Current Hypertension Reports
- Vol. 23 (2) , 1
Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”
- 3 February 2021
- Published by Springer Nature in Current Hypertension Reports
- Vol. 23 (2) , 1
Open AccessResponse to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”
- 27 August 2020
- Published by Springer Nature in Current Hypertension Reports
- Vol. 22 (9) , 1-14
The Story of the Silent Killer
Hypertension is the leading risk factor for death and disability-adjusted life-years lost globally. Despite this tremendous impact on health, blood pressure measurement and treatment are relatively new to medical practice, with widespread measurement beginning just over 100 years ago. How, in such a short time, did blood pressure become such an integral measurement in medical practice that it is now considered one of the vital signs? Key revelations through Stephen Hales and his horse experiment, Riva-Rocci’s modern blood pressure cuff, Korotkoff sounds, and President Roosevelt’s death set the stage for discovery. Landmark trials such as the VA Cooperative studies of the 1960s through the recent Systolic Blood Pressure Intervention Trial and Prevention with Mediterranean Diet trials provide the foundation for modern clinical practice. An understanding of the history of hypertension can directly affect current clinical practice and offers unique insights into how the medical community has approached the management of one of the deadliest medical conditions in history.
- 27 August 2020
- Published by Springer Nature in Current Hypertension Reports
- Vol. 22 (9) , 1-14
The Story of the Silent Killer
Hypertension is the leading risk factor for death and disability-adjusted life-years lost globally. Despite this tremendous impact on health, blood pressure measurement and treatment are relatively new to medical practice, with widespread measurement beginning just over 100 years ago. How, in such a short time, did blood pressure become such an integral measurement in medical practice that it is now considered one of the vital signs? Key revelations through Stephen Hales and his horse experiment, Riva-Rocci’s modern blood pressure cuff, Korotkoff sounds, and President Roosevelt’s death set the stage for discovery. Landmark trials such as the VA Cooperative studies of the 1960s through the recent Systolic Blood Pressure Intervention Trial and Prevention with Mediterranean Diet trials provide the foundation for modern clinical practice. An understanding of the history of hypertension can directly affect current clinical practice and offers unique insights into how the medical community has approached the management of one of the deadliest medical conditions in history.